| 臺大學術典藏 |
2022-09-21T23:32:30Z |
Tumor-Derived C-C Motif Ligand 2 Induces the Recruitment and Polarization of Tumor-Associated Macrophages and Increases the Metastatic Potential of Bladder Cancer Cells in the Postirradiated Microenvironment
|
YUN CHIANG; YU-CHIEH TSAI; Wang, Chung Chieh; FU-JEN HSUEH; Huang, Chao Yuan; Chung, Shiu Dong; CHUNG-HSIN CHEN; YEONG-SHIAU PU; CHIA-HSIEN CHENG |
| 臺大學術典藏 |
2022-03-23T08:16:48Z |
Nuclear Factor-κB Overexpression is Correlated with Poor Outcomes after Multimodality Bladder-Preserving Therapy in Patients with Muscle-Invasive Bladder Cancer
|
CHIANG, YUN; Wang, Chung-Chieh; Yu-Chieh Tsai; Huang, Chao-Yuan; Pu, Yeong-Shiau; Lin, Chia-Chi; Cheng, Jason Chia-Hsien |
| 臺大學術典藏 |
2021-05-27T03:48:21Z |
Targeted Therapy for Renal Cell Carcinoma
|
Yu-Chieh Tsai; Ann-Lii Cheng; YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-03-04T02:36:03Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Yu-Chieh Tsai;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; YU-CHIEH TSAI; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:03Z |
Response of refractory osteosarcoma to thalidomide and celecoxib
|
Yu-Chieh Tsai;Wu C.-T.;Hong R.-L.; YU-CHIEH TSAI; Wu C.-T.; Hong R.-L. |
| 臺大學術典藏 |
2021-03-04T02:36:03Z |
Osteonecrosis of the femoral head in a human immunodeficiency virus type 1-infected patient with lipodystrophy
|
Yu-Chieh Tsai;Liu C.-H.;Liao C.-H.;Chen M.-Y.;Hung C.-C.; YU-CHIEH TSAI; Liu C.-H.; Liao C.-H.; Chen M.-Y.; Hung C.-C. |
| 臺大學術典藏 |
2021-03-04T02:36:02Z |
Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer
|
Chen C.-H.;Shun C.-T.;Huang K.-H.;Huang C.-Y.;Yu-Chieh Tsai;Yu H.-J.;Pu Y.-S.; Chen C.-H.; Shun C.-T.; Huang K.-H.; Huang C.-Y.; YU-CHIEH TSAI; Yu H.-J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:02Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Keng H.-Y.;Yu-Chieh Tsai;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; YU-CHIEH TSAI; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:02Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
Lin C.-C.;Yeh K.-H.;Yang C.-H.;Hsu C.;Yu-Chieh Tsai;Hsu W.-L.;Cheng A.-L.;Hsu C.-H.; Lin C.-C.; Yeh K.-H.; Yang C.-H.; Hsu C.; YU-CHIEH TSAI; Hsu W.-L.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-03-04T02:36:01Z |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; YU-CHIEH TSAI; Hsu F.-M.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:01Z |
Down regulation of ABCD1 in human renal cell carcinoma
|
Hour T.-C.; Kuo Y.-Z.; Liu G.-Y.; Kang W.-Y.; Huang C.-Y.; YU-CHIEH TSAI; Wu W.-J.; Huang S.-P.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:01Z |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Hsu F.-M.; Lin C.-C.; Lee J.-M.; Chang Y.-L.; Hsu C.-H.; YU-CHIEH TSAI; Lee Y.-C.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-04T02:36:01Z |
Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy
|
Hsu F.-M.; Lee Y.-C.; Lee J.-M.; Hsu C.-H.; Lin C.-C.; YU-CHIEH TSAI; Wu J.-K.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-04T02:36:00Z |
Glabridin inhibits migration, invasion, and angiogenesis of human non-small cell lung cancer A549 cells by inhibiting the FAK/Rho signaling pathway
|
Tsai Y.-M.;Yang C.-J.;Hsu Y.-L.;Wu L.-Y.;Yu-Chieh Tsai;Hung J.-Y.;Lien C.-T.;Huang M.-S.;Kuo P.-L.; Tsai Y.-M.; Yang C.-J.; Hsu Y.-L.; Wu L.-Y.; YU-CHIEH TSAI; Hung J.-Y.; Lien C.-T.; Huang M.-S.; Kuo P.-L. |
| 臺大學術典藏 |
2021-03-04T02:36:00Z |
Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma
|
Hsu F.-M.;Lee J.-M.;Huang P.-M.;Lin C.-C.;Hsu C.-H.;Yu-Chieh Tsai;Lee Y.-C.;Chia-Hsien Cheng J.; Hsu F.-M.; Lee J.-M.; Huang P.-M.; Lin C.-C.; Hsu C.-H.; YU-CHIEH TSAI; Lee Y.-C.; Chia-Hsien Cheng J. |
| 臺大學術典藏 |
2021-03-04T02:36:00Z |
Down-regulation of PKC�a in renal cell carcinoma and its clinicopathological implications.
|
Pu Y.S.; Huang C.Y.; Chen J.Y.; Kang W.Y.; Lin Y.C.; Shiu Y.S.; Chuang S.J.; Yu H.J.; Lai M.K.; YU-CHIEH TSAI; Wu W.J.; Hour T.C. |
| 臺大學術典藏 |
2021-03-04T02:35:59Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Yu-Chieh Tsai;Yeh C.-H.;Tzen K.-Y.;Ho P.-Y.;Tuan T.-F.;Pu Y.-S.;Cheng A.-L.;Cheng J.C.-H.; YU-CHIEH TSAI; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; Cheng A.-L.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:59Z |
The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells
|
Xu D.; Lin T.-H.; Zhang C.; YU-CHIEH TSAI; Li S.; Zhang J.; Yin M.; Yeh S.; Chang C. |
| 臺大學術典藏 |
2021-03-04T02:35:59Z |
Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells
|
Huang K.-H.; Kuo K.-L.; Chen S.-C.; Weng T.-I.; Chuang Y.-T.; YU-CHIEH TSAI; Pu Y.-S.; Chiang C.-K.; Liu S.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:59Z |
Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts
|
Yu S.; Yeh C.-R.; Niu Y.; Chang H.-C.; YU-CHIEH TSAI; Moses H.L.; Shyr C.-R.; Chang C.; Yeh S. |
| 臺大學術典藏 |
2021-03-04T02:35:58Z |
MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies
|
Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; Lin W.-C.; YU-CHIEH TSAI; Chang H.-C.; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; Pu Y.-S.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:58Z |
Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells
|
Chen T.-C.;Hsu Y.-L.;Yu-Chieh Tsai;Chang Y.-W.;Kuo P.-L.;Chen Y.-H.; Chen T.-C.; Hsu Y.-L.; YU-CHIEH TSAI; Chang Y.-W.; Kuo P.-L.; Chen Y.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:58Z |
Osteoblast-derived WISP-1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126
|
Tai H.-C.; Chang A.-C.; Yu H.-J.; Huang C.-Y.; YU-CHIEH TSAI; Lai Y.-W.; Sun H.-L.; Tang C.-H.; Wang S.-W. |
| 臺大學術典藏 |
2021-03-04T02:35:58Z |
Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo
|
Hsu I.;Yeh C.-R.;Slavin S.;Miyamoto H.;Netto G.J.;Yu-Chieh Tsai;Muyan M.;Wu X.-R.;Messing E.M.;Guancial E.A.;Yeh S.; Hsu I.; Yeh C.-R.; Slavin S.; Miyamoto H.; Netto G.J.; YU-CHIEH TSAI; Muyan M.; Wu X.-R.; Messing E.M.; Guancial E.A.; Yeh S. |
| 臺大學術典藏 |
2021-03-04T02:35:57Z |
MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma
|
Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; Chang H.-C.; Hsieh J.-T.; Wu J.-T.; Chiang C.-K.; Lin W.-C.; YU-CHIEH TSAI; Chou C.-T.; Hsu C.-H.; Pu Y.-S.; Shi C.-S.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:57Z |
Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma
|
Hsu F.-M.; Hou W.-H.; Huang C.-Y.; Wang C.-C.; Tsai C.-L.; YU-CHIEH TSAI; Yu H.-J.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:57Z |
Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma
|
Hu C.-Y.; YU-CHIEH TSAI; Wang S.-M.; Huang C.-Y.; Tai H.-C.; Chen C.-H.; Pu Y.-S.; Lin W.-C.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:57Z |
Synergistic blockade of EGFR and HER2 by new-generation EGFR tyrosine kinase inhibitor enhances radiation effect in bladder cancer cells
|
YU-CHIEH TSAI; Ho P.-Y.; Tzen K.-Y.; Tuan T.-F.; Liu W.-L.; Cheng A.-L.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:56Z |
CCN3 promotes epithelial-mesenchymal transition in prostate cancer via FAK/Akt/HIF-1�\-induced twist expression
|
Chen P.-C.;Tai H.-C.;Lin T.-H.;Wang S.-W.;Lin C.-Y.;Chao C.-C.;Yu H.-J.;Yu-Chieh Tsai;Lai Y.-W.;Lin C.-W.;Tang C.-H.; Chen P.-C.; Tai H.-C.; Lin T.-H.; Wang S.-W.; Lin C.-Y.; Chao C.-C.; Yu H.-J.; YU-CHIEH TSAI; Lai Y.-W.; Lin C.-W.; Tang C.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:56Z |
Effects of short forest bathing program on autonomic nervous system activity and mood states in middle-aged and elderly individuals
|
Yu C.-P.;Lin C.-M.;Tsai M.-J.;Yu-Chieh Tsai;Chen C.-Y.; Yu C.-P.; Lin C.-M.; Tsai M.-J.; YU-CHIEH TSAI; Chen C.-Y. |
| 臺大學術典藏 |
2021-03-04T02:35:55Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Yu-Chieh Tsai;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; YU-CHIEH TSAI; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:55Z |
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement
|
Chiang Y.;Cheng J.C.-H.;Huang C.-Y.;Yu-Chieh Tsai;Lin C.-C.;Hsu C.-H.;Cheng A.-L.;Pu Y.-S.; Chiang Y.; Cheng J.C.-H.; Huang C.-Y.; YU-CHIEH TSAI; Lin C.-C.; Hsu C.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:35:55Z |
Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population
|
Lin Y.-C.;Hour T.-C.;Yu-Chieh Tsai;Huang S.-P.;Wu W.-J.;Chen C.-H.;Pu Y.-S.;Chung S.-D.;Huang C.-Y.; Lin Y.-C.; Hour T.-C.; YU-CHIEH TSAI; Huang S.-P.; Wu W.-J.; Chen C.-H.; Pu Y.-S.; Chung S.-D.; Huang C.-Y. |
| 臺大學術典藏 |
2021-03-04T02:35:54Z |
Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma
|
Guo J.-C.;Yu-Chieh Tsai;Pu Y.-S.; Guo J.-C.; YU-CHIEH TSAI; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:35:54Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Yu-Chieh Tsai;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; YU-CHIEH TSAI; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:53Z |
Current and future aspect of immunotherapy for advanced renal cell carcinoma
|
Hsueh F.-J.;Yu-Chieh Tsai; Hsueh F.-J.; YU-CHIEH TSAI |
| 臺大學術典藏 |
2021-03-04T02:35:53Z |
Biological significance of GATA3, cytokeratin 20, cytokeratin 5/6 and p53 expression in muscle-invasive bladder cancer
|
Wang C.-C.;Yu-Chieh Tsai;Jeng Y.-M.; Wang C.-C.; YU-CHIEH TSAI; Jeng Y.-M. |
| 臺大學術典藏 |
2021-03-04T02:35:52Z |
Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion
|
Chen J.;Sun Y.;Ou Z.;Yeh S.;Huang C.-P.;You B.;Yu-Chieh Tsai;Sheu T.-J.;Zu X.;Chang C.; Chen J.; Sun Y.; Ou Z.; Yeh S.; Huang C.-P.; You B.; YU-CHIEH TSAI; Sheu T.-J.; Zu X.; Chang C. |
| 臺大學術典藏 |
2021-03-04T02:35:52Z |
Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cells
|
Tien Y.;Tsai C.-L.;Hou W.-H.;Chiang Y.;Hsu F.-M.;Yu-Chieh Tsai;Cheng J.C.-H.; Tien Y.; Tsai C.-L.; Hou W.-H.; Chiang Y.; Hsu F.-M.; YU-CHIEH TSAI; Cheng J.C.-H. |
| 臺大學術典藏 |
2021 |
Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection
|
Tsai M.-C.; Hu T.-H.; Hsiao C.-C.; Chuang C.-H.; Cho W.-R.; Huang P.-Y.; Chen D.-W.; Yong C.-C.; Wu Y.-J.; Liu Y.-W.; Sou F.-M.; YU-CHIEH TSAI |
| 臺大學術典藏 |
2021 |
Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
|
Tsai M.-C.; Hu T.-H.; Hsiao C.-C.; Yen Y.-H.; Yao C.-C.; YU-CHIEH TSAI; Chuang C.-H.; Lin C.-C.; Liu Y.-W.; Chen K.-D.; Wang C.-C.; Yang S.-Y. |
| 臺大學術典藏 |
2020 |
Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery
|
Tsai M.-C.; Hu T.-H.; YU-CHIEH TSAI; Chen K.-D.; Yong C.-C.; Wu Y.-J.; Liu Y.-W.; Wang C.-C.; Lin C.-C.; Chen C.-H.; Hung C.-H.; Cho W.-R. |
| 臺大學術典藏 |
2019 |
Nuclear factor-�eB overexpression is correlated with poor outcomes after multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer
|
Cheng J.C.-H.; Lin C.-C.; Pu Y.-S.; Huang C.-Y.; YU-CHIEH TSAI; Wang C.-C.; Chiang Y. |
| 臺大學術典藏 |
2018-09-10T09:13:59Z |
Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells
|
Chuang, Yuan-Ting; YEONG-SHIAU PU; Tsai, Yu-Chieh; Pu, Yeong-Shiau; Chen, You-Tzung; Huang, K.-H. and Kuo, K.-L. and Chen, S.-C. and Weng, T.-I. and Chuang, Y.-T. and Tsai, Y.-C. and Pu, Y.-S. and Chiang, C.-K. and Liu, S.-H.; Huang, Kuo-How;Kuo, Kuan-Lin;Chen, Shyh-Chyan;Weng, Te-I;Chuang, Yuan-Ting;Tsai, Yu-Chieh;Pu, Yeong-Shiau;Chiang, Chih-Kang;Liu, Shing-Hwa; 蒲永孝;劉興華;蔡育傑;姜至剛;陳世乾;翁德怡;黃國皓; TE-I WENG; CHIH-KANG CHIANG; YU-CHIEH TSAI; Kuo, Kuan-Lin; Chen, Shyh-Chyan; SHING-HWA LIU; KUO-HOW HUANG |
| 臺大學術典藏 |
2018-09-10T08:30:06Z |
Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma
|
Hsu, F.-M. and Lee, J.-M. and Huang, P.-M. and Lin, C.-C. and Hsu, C.-H. and Tsai, Y.-C. and Lee, Y.-C. and Chia-Hsien Cheng, J.; CHIH-HUNG HSU; JANG-MING LEE; PEI-MING HUANG; YU-CHIEH TSAI |
| 臺大學術典藏 |
2018-09-10T07:21:37Z |
Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy
|
Hsu, F.-M. and Lee, Y.-C. and Lee, J.-M. and Hsu, C.-H. and Lin, C.-C. and Tsai, Y.-C. and Wu, J.-K. and Cheng, J.C.-H.; CHIH-HUNG HSU; JANG-MING LEE; YU-CHIEH TSAI |
| 臺大學術典藏 |
2018-09-10T06:49:26Z |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Hsu, F.-M. and Lin, C.-C. and Lee, J.-M. and Chang, Y.-L. and Hsu, C.-H. and Tsai, Y.-C. and Lee, Y.-C. and Cheng, J.C.-H.; YIH-LEONG CHANG; CHIH-HUNG HSU; JANG-MING LEE; YU-CHIEH TSAI |
| 臺大學術典藏 |
2018-09-10T06:13:47Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Lin, Chia-Chi;Chih-Hung;Hsu;Huang, Chao-Yuan;Keng, Hsiao-Yi;Tsai, Yu-Chieh;Huang, Kuo-How;Cheng, Ann-Lii;Pu, Yeong-Shiau; Lin, C.-C. and Hsu, C.-H. and Huang, C.-Y. and Keng, H.-Y. and Tsai, Y.-C. and Huang, K.-H. and Cheng, A.-L. and Pu, Y.-S.; Lin, Chia-Chi; CHAO-YUAN HUANG; CHIH-HUNG HSU; Chih-Hung; Hsu; KUO-HOW HUANG; YU-CHIEH TSAI; Huang, Chao-Yuan; ANN-LII CHENG; Keng, Hsiao-Yi; Tsai, Yu-Chieh; YEONG-SHIAU PU; Huang, Kuo-How; Cheng, Ann-Lii; Pu, Yeong-Shiau |
| 國立交通大學 |
2014-12-12T02:09:59Z |
以科技接受模式探討消費者接受智慧型自動租片機的行為意圖
|
蔡雨絜; Yu-Chieh Tsai; 黃仁宏; 許和鈞; Jen-Hung Huang; Her-Jiun Sheu |
| 中國醫藥大學 |
2014-09 |
Osteoblast-derived Wnt-1-induced secreted protein 1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126
|
(Huai-Ching Tai);(An-Chen Chang);(Hong-Jeng Yu);(Chao-Yuan Huang);(Yu-Chieh Tsai);(Yu-Wei Lai);(Hui-Lung Sun);湯智昕(Tang Chih-Hsin)*;(Shih-Wei Wang)* |
